According to Gram Research analysis, a 2026 study of 67 people with metabolic syndrome found that those who also had COPD showed significantly lower vitamin D levels and higher inflammation markers including C-reactive protein, triglycerides, and cholesterol. The research suggests doctors should screen people with metabolic syndrome for undiagnosed lung disease and monitor these specific blood markers to catch COPD early.
A new study from Malta reveals an important connection between metabolic syndrome (a cluster of health conditions including high blood pressure, blood sugar, and cholesterol) and COPD, a serious lung disease. Researchers tested 67 people with metabolic syndrome and found that those who also had COPD showed significantly worse health markers, including lower vitamin D levels and higher inflammation. The study suggests that doctors should screen people with metabolic syndrome for lung problems and monitor specific blood markers like vitamin D, cholesterol, and inflammation levels to catch COPD early.
Key Statistics
A 2026 study of 67 people with metabolic syndrome from Malta found that those with COPD had significantly lower vitamin D levels compared to those without COPD (p=0.030 for smokers, p=0.043 for non-smokers).
According to research reviewed by Gram, people with metabolic syndrome and COPD showed significantly higher C-reactive protein (p=0.036), triglycerides (p=0.023), and total cholesterol (p=0.039) compared to smokers without COPD.
A 2026 Maltese study of 67 metabolic syndrome patients found that those with COPD reported significantly worse lung function, exercise capacity, and mental health outcomes including depression and fatigue compared to those without COPD.
The Quick Take
- What they studied: Whether people with metabolic syndrome (a group of health problems including high blood pressure, blood sugar, and cholesterol) also have undiagnosed lung disease called COPD, and what blood markers differ between those with and without COPD.
- Who participated: 67 people from Malta’s main hospital who had metabolic syndrome and diabetes. They were divided into three groups: those with both metabolic syndrome and COPD, those with metabolic syndrome and a smoking history but no COPD, and those with metabolic syndrome but no smoking history.
- Key finding: People with both metabolic syndrome and COPD had significantly worse lung function, lower vitamin D levels, and higher inflammation markers (including C-reactive protein, triglycerides, and cholesterol) compared to those with metabolic syndrome alone.
- What it means for you: If you have metabolic syndrome or diabetes, ask your doctor about screening for COPD, especially if you smoke or have breathing problems. Monitoring vitamin D, cholesterol, and inflammation levels may help catch lung disease early. However, this is a small study from one hospital, so results should be confirmed with larger research.
The Research Details
Researchers recruited 67 people with metabolic syndrome from Malta’s main general hospital and divided them into three groups for comparison. The main study group had metabolic syndrome plus COPD, while two control groups had metabolic syndrome without COPD (one with a smoking history, one without). All participants completed breathing tests, walked for six minutes to measure exercise capacity, answered questionnaires about lung symptoms and depression, and had blood tests to measure vitamin D, cholesterol, triglycerides, and inflammation markers.
The researchers used several standardized tools to assess lung health: spirometry (a breathing test), the COPD Assessment Test (CAT), and the St. George’s Respiratory Questionnaire (SGRQ-C). They also measured depression and fatigue using validated scales. This multi-layered approach allowed them to compare not just lung function but overall health and quality of life between groups.
By comparing people with metabolic syndrome who had COPD to those without COPD, the researchers could identify which blood markers and health measurements were most different, suggesting they might help doctors identify COPD in people with metabolic syndrome.
Most research focuses on whether people with COPD develop metabolic syndrome, but this study flips the question: do people with metabolic syndrome have undiagnosed COPD? This is important because both conditions cause inflammation in the body, and having both together could be especially harmful. By identifying specific blood markers that differ between groups, doctors might be able to screen for COPD more easily in people with metabolic syndrome.
This study has several strengths: it used multiple validated assessment tools, compared three groups rather than just two, and measured both lung function and blood markers. However, it has important limitations: only 67 people from one hospital in Malta participated, which is a small sample size. The study is observational rather than experimental, meaning it shows associations but cannot prove cause-and-effect. Results may not apply to other populations with different genetics or healthcare systems. Larger, multi-center studies are needed to confirm these findings.
What the Results Show
People with metabolic syndrome who also had COPD showed significantly worse outcomes across nearly every measure compared to those without COPD. Their lung function (measured by spirometry) was substantially lower, and they reported more breathing difficulty on the modified Medical Research Council scale. They also scored worse on the COPD Assessment Test and St. George’s Respiratory Questionnaire, indicating more severe symptoms and greater impact on daily life.
The most striking finding involved vitamin D: people with metabolic syndrome and COPD had significantly lower vitamin D levels compared to both smokers without COPD and non-smokers without COPD. Additionally, those with COPD had higher levels of C-reactive protein (a marker of inflammation), triglycerides (a type of fat in blood), and total cholesterol compared to smokers without COPD.
Mental health markers also differed significantly. People with metabolic syndrome and COPD reported more depression symptoms on the Center for Epidemiological Studies Depression scale and greater fatigue on the Functional Assessment of Chronic Illness Therapy Fatigue scale. These findings suggest that COPD in people with metabolic syndrome affects not just physical health but emotional wellbeing too.
The study found that people with COPD and metabolic syndrome had lower exercise capacity on the six-minute walk test, meaning they couldn’t walk as far before becoming tired. The BODE index (which combines body mass index, lung obstruction, breathing difficulty, and exercise capacity) was significantly worse in the COPD group. Depression and fatigue were more common in people with both conditions, suggesting these mental health issues should be screened for and treated in this population.
Previous research has extensively studied whether people with COPD develop metabolic syndrome, but this study addresses the less-studied question of whether people with metabolic syndrome have undiagnosed COPD. The findings align with what we know about inflammation: both COPD and metabolic syndrome are inflammatory conditions, and having both together appears to create a more severe inflammatory state. The vitamin D finding is particularly interesting because low vitamin D has been linked to both COPD and metabolic syndrome in previous research, suggesting it may be a common underlying factor.
The study included only 67 people from one hospital in Malta, which is a small sample size that may not represent other populations. The study is observational, meaning researchers observed associations but cannot prove that low vitamin D causes COPD or vice versa. The study doesn’t explain why these associations exist or whether treating low vitamin D would improve COPD outcomes. Results may not apply to people in other countries with different genetics, diets, or healthcare systems. The study doesn’t account for all possible factors that might affect results, such as medication use or diet quality.
The Bottom Line
If you have metabolic syndrome or diabetes, discuss COPD screening with your doctor, especially if you smoke or have symptoms like persistent cough or shortness of breath. Ask your doctor to check your vitamin D, cholesterol, triglycerides, and inflammation markers (C-reactive protein). If you’re diagnosed with both metabolic syndrome and COPD, ask about screening for depression and fatigue, as these are common in this population. These recommendations are based on a single small study, so they should be discussed with your healthcare provider rather than acted upon independently.
People with metabolic syndrome, diabetes, or a history of smoking should pay attention to this research. Healthcare providers treating patients with metabolic syndrome should consider screening for COPD. People already diagnosed with both conditions should ensure they’re being monitored for depression and fatigue. However, people without metabolic syndrome or COPD don’t need to change their behavior based on this study alone.
If you’re screened and found to have COPD, treatment benefits may appear over weeks to months. Vitamin D supplementation, if recommended by your doctor, typically takes 2-3 months to raise blood levels. Improvements in lung function with COPD treatment usually appear within 4-12 weeks. Mental health improvements from treating depression or fatigue may take 4-8 weeks.
Frequently Asked Questions
What is metabolic syndrome and how does it relate to lung disease?
Metabolic syndrome is a cluster of health problems including high blood pressure, high blood sugar, excess belly fat, and abnormal cholesterol levels. Both metabolic syndrome and COPD cause inflammation in the body. This 2026 study found that people with metabolic syndrome are more likely to have undiagnosed COPD, and those with both conditions show worse health markers.
Should I get screened for COPD if I have metabolic syndrome?
If you have metabolic syndrome, especially with a smoking history or breathing symptoms, discuss COPD screening with your doctor. This study suggests screening may be beneficial, but it’s a small study from one hospital. Your doctor can assess your individual risk factors and recommend appropriate testing.
What blood tests should I ask my doctor about if I have metabolic syndrome?
Ask your doctor to check vitamin D levels, C-reactive protein (inflammation marker), triglycerides, and total cholesterol. This 2026 study found these markers were significantly different in people with metabolic syndrome who also had COPD, suggesting they may help identify undiagnosed lung disease.
Can low vitamin D cause COPD or metabolic syndrome?
This study found an association between low vitamin D and COPD in people with metabolic syndrome, but it cannot prove vitamin D deficiency causes these conditions. Low vitamin D may be a marker of disease rather than a cause. More research is needed to determine whether vitamin D supplementation improves outcomes.
Is depression common in people with both metabolic syndrome and COPD?
This 2026 study found that people with metabolic syndrome and COPD reported significantly more depression and fatigue symptoms compared to those without COPD. The researchers recommend screening for depression and fatigue in this population, as treating these conditions may improve overall health outcomes.
Want to Apply This Research?
- Track your vitamin D levels quarterly, monitor cholesterol and triglyceride levels every 3-6 months, and log any changes in breathing difficulty, fatigue, or mood using a simple 1-10 scale daily.
- Set reminders to take vitamin D supplements if recommended by your doctor, schedule quarterly blood work to monitor inflammation markers and lipids, and log breathing symptoms or fatigue episodes to share with your healthcare provider.
- Create a health dashboard showing trends in vitamin D, cholesterol, triglycerides, and C-reactive protein over time. Track respiratory symptoms and fatigue weekly. Set alerts when values fall outside your target ranges so you can contact your doctor proactively.
This research describes associations found in a small study of 67 people from one hospital in Malta and should not be used for self-diagnosis. If you have symptoms of COPD (persistent cough, shortness of breath, wheezing) or have been diagnosed with metabolic syndrome, consult your healthcare provider for personalized evaluation and screening recommendations. Do not start, stop, or change any medications or supplements based on this study without discussing with your doctor. This article is for educational purposes and does not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.